Autolus Therapeutics Reports Third Quarter 2020 Financial Results and Operational Progress

NEXT STORY
Kiniksa Reports Third Quarter 2020 Financial Results and Highlights Recent Pipeline and Corporate Activity
PREV STORY
Madrigal Pharmaceuticals Announces Completion of Enrollment in Phase 3 MAESTRO NAFLD-1 Trial and Reports 2020 Third Quarter Financial Results and Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Invivoscribe Announces a Regional “Center of Excellence” Reference Laboratory in Beirut to Offer Specialized Gene Panels

SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- Invivoscribe Technologies Inc., a global precision diagnostics ...

author_avatar
NASDAQ Market News

Novartis data at AAN show Mayzent’s® positive impact on cognitive processing speed, a core element of cognitive function, in people living with secondary progressive MS

author_avatar
NASDAQ Market News

VBL Therapeutics to Present at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City on September 12th, 2016

TEL AVIV, Israel, Sept. 06, 2016 (GLOBE NEWSWIRE) -- VBL THERAPEUTICS (NASDAQ:VBLT), today announced ...

author_avatar
NASDAQ Market News